Spero Therapeutics (SPRO) Change in Account Payables (2016 - 2026)
Spero Therapeutics posted quarterly Change in Account Payables of -$476000.0 for Q1 2026, up 91.41% year-on-year from -$248681.5 in Q1 2025, and up 32.19% on a QoQ basis from -$702000.0 in Q4 2025.
Spero Therapeutics (SPRO) has 11 years of Change in Account Payables data on file, last reported at -$476000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 91.41% year-over-year to -$476000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (down 18.99% YoY), and the FY2025 full-year result was -$6.6 million, down 211.56% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$476000.0, up from -$702000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.7 million in Q1 2022 and bottomed at -$5.5 million in Q1 2025.
- The 5-year median for Change in Account Payables is -$34000.0 (2023), against an average of -$52000.0.
- The widest annual swing landed in 2024, when Change in Account Payables soared 5064.71%; it then plunged 428.26% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$2.0 million in 2022, then jumped by 113.98% to $275000.0 in 2023, then surged by 342.18% to $1.2 million in 2024, then tumbled by 157.73% to -$702000.0 in 2025, then jumped by 32.19% to -$476000.0 in 2026.
- The last three Change in Account Payables figures came in at -$476000.0 (Q1 2026), -$702000.0 (Q4 2025), and $615000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | -476,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -476,000.00 |
| Mar 31, 2026 | -476,000.00 |
| Dec 31, 2025 | -702,000.00 |
| Dec 31, 2025 | -702,000.00 |
| Sep 30, 2025 | 615,000.00 |
| Sep 30, 2025 | 615,000.00 |
| Jun 30, 2025 | -985,000.00 |
| Jun 30, 2025 | -985,000.00 |
| Mar 31, 2025 | -5.54 Mn |
| Mar 31, 2025 | -5.54 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | -370,000.00 |
| Jun 30, 2024 | -370,000.00 |
| Mar 31, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 275,000.00 |
| Dec 31, 2023 | 275,000.00 |
| Sep 30, 2023 | -207,000.00 |
| Sep 30, 2023 | -207,000.00 |
| Jun 30, 2023 | 727,000.00 |
| Jun 30, 2023 | 727,000.00 |
| Mar 31, 2023 | -34,000.00 |
| Mar 31, 2023 | -34,000.00 |
| Dec 31, 2022 | -1.97 Mn |
| Dec 31, 2022 | -1.97 Mn |
| Sep 30, 2022 | 871,000.00 |
| Sep 30, 2022 | 871,000.00 |
| Jun 30, 2022 | -3.07 Mn |
| Jun 30, 2022 | -3.07 Mn |
| Mar 31, 2022 | 3.68 Mn |
| Mar 31, 2022 | 3.68 Mn |
| Dec 31, 2021 | -2.06 Mn |
| Dec 31, 2021 | -2.06 Mn |
| Sep 30, 2021 | 1.53 Mn |
| Sep 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | -2.21 Mn |
| Jun 30, 2021 | -2.21 Mn |
| Mar 31, 2021 | 2.69 Mn |
| Mar 31, 2021 | 2.69 Mn |
| Dec 31, 2020 | -1.32 Mn |
| Dec 31, 2020 | -1.32 Mn |
| Sep 30, 2020 | 911,000.00 |
| Sep 30, 2020 | 911,000.00 |
| Jun 30, 2020 | -7.39 Mn |
| Jun 30, 2020 | -7.39 Mn |
| Mar 31, 2020 | 4.82 Mn |
| Mar 31, 2020 | 4.82 Mn |
| Dec 31, 2019 | 1.61 Mn |
| Dec 31, 2019 | 1.61 Mn |
| Sep 30, 2019 | 1.49 Mn |
| Sep 30, 2019 | 1.49 Mn |
| Jun 30, 2019 | 482,000.00 |
| Jun 30, 2019 | 482,000.00 |
| Mar 31, 2019 | -3.01 Mn |
| Mar 31, 2019 | -3.01 Mn |
| Dec 31, 2018 | 2.17 Mn |
| Dec 31, 2018 | 2.17 Mn |
| Sep 30, 2018 | 659,000.00 |
| Sep 30, 2018 | 659,000.00 |
| Jun 30, 2018 | -278,000.00 |
| Jun 30, 2018 | -278,000.00 |
| Mar 31, 2018 | -2.47 Mn |
| Mar 31, 2018 | -2.47 Mn |
| Dec 31, 2017 | 2.46 Mn |
| Dec 31, 2017 | 2.46 Mn |
| Sep 30, 2017 | -230,000.00 |
| Sep 30, 2017 | -230,000.00 |
| Jun 30, 2017 | 200,000.00 |
| Jun 30, 2017 | 200,000.00 |
| Mar 31, 2017 | -82,000.00 |
| Mar 31, 2017 | -82,000.00 |
| Dec 31, 2016 | 35,000.00 |
| Dec 31, 2016 | 35,000.00 |